{"id":"ym443","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL2107723","moleculeType":"Small molecule","molecularWeight":"450.56"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting the serotonin reuptake transporter, YM443 increases the levels of serotonin in the synaptic cleft, which can help to improve mood and reduce symptoms of depression. This mechanism of action is similar to that of selective serotonin reuptake inhibitors (SSRIs).","oneSentence":"YM443 is a selective and potent inhibitor of the serotonin reuptake transporter.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:41:13.846Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"}]},"trialDetails":[{"nctId":"NCT04526119","phase":"PHASE3","title":"A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zeria Pharmaceutical","startDate":"2021-02-22","conditions":"Functional Dyspepsia","enrollment":55},{"nctId":"NCT07449689","phase":"PHASE4","title":"Comparing Acotiamide and Itopride for the Management of Indigestion","status":"NOT_YET_RECRUITING","sponsor":"Aga Khan University","startDate":"2026-04","conditions":"Functioanl Dyspepsia, Post Prandial Distress Syndrome","enrollment":368},{"nctId":"NCT07174297","phase":"PHASE3","title":"Acotiamide vs Itopride in Postprandial Distress Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Getz Pharma","startDate":"2025-10-30","conditions":"Postprandial Distress Syndrome","enrollment":152},{"nctId":"NCT04697641","phase":"NA","title":"Helicobacter Pylori Eradication in Functional Dyspepsia","status":"COMPLETED","sponsor":"Sir Ganga Ram Hospital","startDate":"2017-09-01","conditions":"Dyspepsia, Helicobacter Pylori Infection","enrollment":202},{"nctId":"NCT03402984","phase":"NA","title":"Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2017-04-01","conditions":"Healthy","enrollment":20},{"nctId":"NCT00102310","phase":"PHASE2","title":"YM443 in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2004-03-10","conditions":"Indigestion, Nausea","enrollment":416},{"nctId":"NCT01973790","phase":"PHASE3","title":"Phase III, Long-term, Open-label Safety Study of Z-338","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2014-03","conditions":"Dyspepsia","enrollment":207},{"nctId":"NCT00323817","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2006-04","conditions":"Functional Dyspepsia","enrollment":282},{"nctId":"NCT00764374","phase":"PHASE3","title":"A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2008-08","conditions":"Dyspepsia, Functional Dyspepsia","enrollment":412},{"nctId":"NCT00850746","phase":"PHASE1","title":"A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-02","conditions":"Functional Dyspepsia","enrollment":80},{"nctId":"NCT00761358","phase":"PHASE3","title":"To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2008-09","conditions":"Functional Dyspepsia","enrollment":820},{"nctId":"NCT00458328","phase":"PHASE2","title":"The Effect of Z-338 in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2007-04","conditions":"Functioanl Dyspepsia","enrollment":40},{"nctId":"NCT00920998","phase":"PHASE1","title":"Effect of Food Intake on Pharmacokinetic Profiles of Z-338","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-03","conditions":"Healthy","enrollment":30},{"nctId":"NCT00333372","phase":"PHASE2","title":"To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2006-04","conditions":"Functional Dyspepsia","enrollment":440},{"nctId":"NCT00298194","phase":"PHASE2","title":"The Effects of Z-338 in Subjects With and Without Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2006-02","conditions":"Dyspepsia","enrollment":52}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Z-338","acotiamide","acotiamide hydrochloride"],"phase":"phase_3","status":"active","brandName":"YM443","genericName":"YM443","companyName":"Astellas Pharma Inc","companyId":"astellas-pharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"YM443 is a selective and potent inhibitor of the serotonin reuptake transporter. Used for Major depressive disorder.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}